Go to deals
Healthcare | Private Equity

Southwestern Eye Center, Ltd. has completed a recapitalization with H.I.G. Capital

Southwestern Eye Center, Ltd. (SW Eye) has completed a recapitalization with H.I.G. Capital.

Founded in 1982, SW Eye is one of the largest eye care physician practices in the southwest, providing comprehensive optometry and ophthalmology services, including subspecialty procedures in vitreoretinal disease, oculoplastics, cornea disease, glaucoma, refractive procedures, low vision aids and ocular prosthetics through 23 locations in Arizona and one in New Mexico. SW Eye employs 17 ophthalmologists and 21 optometrists and is headquartered in Mesa, Arizona. The company is a highly regarded clinical organization with leadership positions in various academic organizations and industry trade groups.

H.I.G. Capital is a leading global private equity and alternative assets investment firm with US$21 billion of equity capital under management. Based in Miami and with offices in New York, Boston, Chicago, Dallas, Los Angeles, San Francisco, and Atlanta in the US, as well as international affiliate offices in London, Hamburg, Madrid, Milan, Paris, Bogotá, Mexico City and Rio de Janeiro, H.I.G. Capital specializes in providing both debt and equity capital to small and mid-sized companies, utilizing a flexible and operationally focused value-added approach. Since its founding in 1993, the firm has invested in and managed more than 200 companies worldwide. Its current portfolio includes more than 100 companies with combined sales in excess of US$30 billion.

Oaklins' team in Los Angeles acted as financial advisor to the seller in this transaction.

Parties

Talk to the deal team

Gary Rabishaw

Managing Director
Los Angeles, United States
Oaklins Intrepid

Ryan Makis

Director
Los Angeles, United States
Oaklins Intrepid

Kyle Kearney

Associate Director
Los Angeles, United States
Oaklins Intrepid

Related deals

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Healthcare

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval

Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.

Learn more
Dolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth
Private Equity | Business Support Services | Construction & Engineering Services

Dolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth

Dolmans Landscaping Group, a leading full-service provider of landscaping services, has welcomed Foreman Capital as a new shareholder. By partnering with Foreman Capital, which has extensive experience in building stronger companies in the maintenance of public spaces, Dolmans can accelerate its growth trajectory across core verticals and further professionalize the business.

Learn more
Nuzoa has acquired Agrofauna
Private Equity | Consumer & Retail

Nuzoa has acquired Agrofauna

Nuzoa, a provider of value-added services for pets and livestock in the Iberian Peninsula, has acquired 100% of Agrofauna. This transaction reinforces Nuzoa’s presence in the Portuguese market, particularly in the northern region, marking another step toward its ambition to become the leading operator while further consolidating its brand across Iberia.

Learn more